MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research

Conditions

Prostate

Phase I

Volunteers
Health Professionals

What is the purpose of this trial?

We hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and phenotypic signatures. the Artemis system will be used to collect one extra research biopsy from each ROI. An average of 2 ROIs are identified for each case; therefore an average of 2 additional biopsies would be required for this research study. These research biopsies will not affect prostate biopsies collected as part of standard clinical care.

Ages
18 years - 80 years
Gender
Male only

Find out more about who can participate in this trial

Trial with
Yale University School of Medicine
Start Date
06/24/2013
End Date
10/31/2023

For more information about this study, contact:

Jamil Syed

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Preston C. Sprenkle, MD
Associate Professor of Urology; Co-Chair, Cancer Liaison Committee, Oncology; Co-Chair, NCCN Guidelines Committee on Prostate Cancer Early Detection; Division Chief, Division of Urology at VA Connecticut Healthcare System, Urology; Director, Urology Research Fellowship, Urology; Director, Urologic Oncology Clinical Fellowship Program, Urology

Sub-Investigators

Last Updated
07/15/2021
Study HIC
#1304011902

MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research

Conditions

Volunteers

Health Professionals

What is the purpose of this trial?

I'm interested in volunteering

Principal Investigator

Sub-Investigators

Contact Information